BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28049360)

  • 1. Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    Clin Appl Thromb Hemost; 2017 May; 23(4):319-328. PubMed ID: 28049360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2016 Jul; 42(1):135-41. PubMed ID: 26743062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Dahlbäck B; Svensson PJ; Sundquist J; Memon AA
    Thromb Haemost; 2016 Aug; 116(3):432-41. PubMed ID: 27277397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thrombomodulin gene polymorphisms on venous thromboembolism: An analysis of evidence involving 6,629 patients.
    Wang L; Ran L; Tian Y; Jin Y; Yi J; He X
    Vascular; 2024 Apr; 32(2):374-384. PubMed ID: 36278273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.
    Navarro S; Medina P; Bonet E; Corral J; Martínez-Sales V; Martos L; Rivera M; Roselló-Lletí E; Alberca I; Roldán V; Mira Y; Ferrando F; Estellés A; Vicente V; Bertina RM; España F
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1435-40. PubMed ID: 23520161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study.
    Manderstedt E; Halldén C; Lind-Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
    J Thromb Haemost; 2022 Apr; 20(4):929-935. PubMed ID: 34970867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombomodulin gene polymorphism and the occurrence and prognostic value of sepsis acute kidney injury.
    Li Q; Yang W; Zhao K; Sun X; Bao L
    Medicine (Baltimore); 2021 Jul; 100(26):e26293. PubMed ID: 34190147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2017 Jul; 44(1):130-138. PubMed ID: 28321710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Nucleotide Polymorphisms Within the Thrombomodulin Gene (THBD) Predict Mortality in Patients With Graft-Versus-Host Disease.
    Rachakonda SP; Penack O; Dietrich S; Blau O; Blau IW; Radujkovic A; Isermann B; Ho AD; Uharek L; Dreger P; Kumar R; Luft T
    J Clin Oncol; 2014 Oct; 32(30):3421-7. PubMed ID: 25225421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.
    Donadini MP; Ageno W; Antonucci E; Cosmi B; Kovacs MJ; Le Gal G; Ockelford P; Poli D; Prandoni P; Rodger M; Saccullo G; Siragusa S; Young L; Bonzini M; Caprioli M; Dentali F; Iorio A; Douketis JD
    Thromb Haemost; 2014 Jan; 111(1):172-9. PubMed ID: 24154729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.
    Sundquist K; Sundquist J; Svensson PJ; Zöller B; Memon AA
    J Thromb Haemost; 2015 Dec; 13(12):2180-6. PubMed ID: 26407905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of gene polymorphisms with the risk of warfarin bleeding complications at therapeutic INR in patients with mechanical cardiac valves.
    An SH; Lee KE; Chang BC; Gwak HS
    J Clin Pharm Ther; 2014 Jun; 39(3):314-8. PubMed ID: 24602049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
    Franco Moreno AI; García Navarro MJ; Ortiz Sánchez J; Martín Díaz RM; Madroñal Cerezo E; de Ancos Aracil CL; Cabello Clotet N; Perales Fraile I; Gimeno García S; Montero Hernández C; Zapatero Gaviria A; Ruiz Giardín JM
    Eur J Intern Med; 2016 Apr; 29():59-64. PubMed ID: 26775136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.
    Sundquist K; Ahmad A; Svensson PJ; Zöller B; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2018 Aug; 46(2):154-165. PubMed ID: 29671165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism.
    Tripodi A; Legnani C; Chantarangkul V; Cosmi B; Palareti G; Mannucci PM
    J Thromb Haemost; 2008 Aug; 6(8):1327-33. PubMed ID: 18485081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel genetic predictors of venous thromboembolism risk in African Americans.
    Hernandez W; Gamazon ER; Smithberger E; O'Brien TJ; Harralson AF; Tuck M; Barbour A; Kittles RA; Cavallari LH; Perera MA
    Blood; 2016 Apr; 127(15):1923-9. PubMed ID: 26888256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.